MedTrace Logo

To Evaluate the Pharmacokinetic Interactions and Safety Between Fimasartan and Rosuvastatin

NCT01921946 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2013-10-22

No results posted yet for this study

Summary

A phase Ⅰ study to evaluate the pharmacokinetic interactions and safety between fimasartan and rosuvastatin in healthy male volunteers.

Conditions

Interventions

DRUG

Fimasartan

DRUG

Rosuvastatin

Sponsors & Collaborators

  • Kyungpook National University Hospital

    collaborator OTHER

  • Boryung Pharmaceutical Co., Ltd

    lead INDUSTRY

Principal Investigators

  • Young Ran Yoon, M.D., Ph.D. · Kyungpook National University Hospital

Study Design

Allocation
NON_RANDOMIZED
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2013-09-30
Completion
2013-10-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01921946 on ClinicalTrials.gov